Does the media favor TMO or ILMN?

In the previous week, Thermo Fisher Scientific had 81 more articles in the media than Illumina. MarketBeat recorded 103 mentions for Thermo Fisher Scientific and 22 mentions for Illumina. Thermo Fisher Scientific's average media sentiment score of 1.60 beat Illumina's score of 1.52 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 98 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive Illumina 20 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor TMO or MEDP?

In the previous week, Thermo Fisher Scientific had 78 more articles in the media than Medpace. MarketBeat recorded 103 mentions for Thermo Fisher Scientific and 25 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 1.60 beat Medpace's score of 1.13 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 98 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive Medpace 19 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor A or TMO?

In the previous week, Thermo Fisher Scientific had 72 more articles in the media than Agilent Technologies. MarketBeat recorded 103 mentions for Thermo Fisher Scientific and 31 mentions for Agilent Technologies. Thermo Fisher Scientific's average media sentiment score of 1.60 beat Agilent Technologies' score of 1.54 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 28 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Thermo Fisher Scientific 98 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor TMO or AMN?

In the previous week, Thermo Fisher Scientific had 93 more articles in the media than AMN Healthcare Services. MarketBeat recorded 103 mentions for Thermo Fisher Scientific and 10 mentions for AMN Healthcare Services. Thermo Fisher Scientific's average media sentiment score of 1.60 beat AMN Healthcare Services' score of 0.82 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 98 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive AMN Healthcare Services 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor TMO or BIO?

In the previous week, Thermo Fisher Scientific had 99 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 103 mentions for Thermo Fisher Scientific and 4 mentions for Bio-Rad Laboratories. Thermo Fisher Scientific's average media sentiment score of 1.60 beat Bio-Rad Laboratories' score of 1.08 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 98 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive Bio-Rad Laboratories 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Thermo Fisher Scientific (TMO) Competitors

$618.88 +5.34 (+0.87%)

As of 10:07 AM Eastern

Compare

TMO vs. ILMN, MEDP, A, AMN, and BIO

Should you buy Thermo Fisher Scientific stock or one of its competitors? Thermo Fisher Scientific's main competitors and comparable companies include Illumina (ILMN), Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), and Bio-Rad Laboratories (BIO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Thermo Fisher Scientific compare to Illumina?

Thermo Fisher Scientific (NYSE:TMO) and Illumina (NASDAQ:ILMN) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 89.4% of Illumina shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 2.9% of Illumina shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Illumina has a net margin of 18.36% compared to Thermo Fisher Scientific's net margin of 15.04%. Illumina's return on equity of 29.84% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.04%	17.09%	8.12%
Illumina	18.36%	29.84%	12.17%

In the previous week, Thermo Fisher Scientific had 81 more articles in the media than Illumina. MarketBeat recorded 103 mentions for Thermo Fisher Scientific and 22 mentions for Illumina. Thermo Fisher Scientific's average media sentiment score of 1.60 beat Illumina's score of 1.52 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	98 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Illumina	20 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Thermo Fisher Scientific has higher revenue and earnings than Illumina. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	5.14	$6.70B	$18.59	33.29
Illumina	$4.34B	7.36	$850M	$5.36	39.51

Thermo Fisher Scientific has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market. Comparatively, Illumina has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market.

Thermo Fisher Scientific presently has a consensus target price of $619.41, suggesting a potential upside of 0.09%. Illumina has a consensus target price of $188.40, suggesting a potential downside of 11.04%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, equities research analysts clearly believe Thermo Fisher Scientific is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.78
Illumina	2 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.47

Summary

Thermo Fisher Scientific and Illumina tied by winning 8 of the 16 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to Medpace?

Thermo Fisher Scientific (NYSE:TMO) and Medpace (NASDAQ:MEDP) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

Thermo Fisher Scientific has higher revenue and earnings than Medpace. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	5.14	$6.70B	$18.59	33.29
Medpace	$2.53B	6.83	$451.12M	$17.06	36.32

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by company insiders. Comparatively, 20.5% of Medpace shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Medpace has a net margin of 17.67% compared to Thermo Fisher Scientific's net margin of 15.04%. Medpace's return on equity of 110.15% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.04%	17.09%	8.12%
Medpace	17.67%	110.15%	24.84%

In the previous week, Thermo Fisher Scientific had 78 more articles in the media than Medpace. MarketBeat recorded 103 mentions for Thermo Fisher Scientific and 25 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 1.60 beat Medpace's score of 1.13 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	98 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Medpace	19 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Thermo Fisher Scientific currently has a consensus target price of $619.41, suggesting a potential upside of 0.09%. Medpace has a consensus target price of $584.18, suggesting a potential downside of 5.71%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, research analysts plainly believe Thermo Fisher Scientific is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.78
Medpace	0 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.23

Thermo Fisher Scientific has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market. Comparatively, Medpace has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market.

Summary

Thermo Fisher Scientific beats Medpace on 10 of the 17 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

In the previous week, Thermo Fisher Scientific had 72 more articles in the media than Agilent Technologies. MarketBeat recorded 103 mentions for Thermo Fisher Scientific and 31 mentions for Agilent Technologies. Thermo Fisher Scientific's average media sentiment score of 1.60 beat Agilent Technologies' score of 1.54 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	28 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Thermo Fisher Scientific	98 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Agilent Technologies currently has a consensus price target of $160.24, suggesting a potential upside of 2.87%. Thermo Fisher Scientific has a consensus price target of $619.41, suggesting a potential upside of 0.09%. Given Agilent Technologies' stronger consensus rating and higher possible upside, research analysts plainly believe Agilent Technologies is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	2.89
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.78

Agilent Technologies has a net margin of 19.55% compared to Thermo Fisher Scientific's net margin of 15.04%. Agilent Technologies' return on equity of 24.33% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.55%	24.33%	12.99%
Thermo Fisher Scientific	15.04%	17.09%	8.12%

89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Agilent Technologies pays an annual dividend of $1.02 per share and has a dividend yield of 0.7%. Thermo Fisher Scientific pays an annual dividend of $1.88 per share and has a dividend yield of 0.3%. Agilent Technologies pays out 20.5% of its earnings in the form of a dividend. Thermo Fisher Scientific pays out 10.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies has raised its dividend for 9 consecutive years and Thermo Fisher Scientific has raised its dividend for 8 consecutive years. Agilent Technologies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Agilent Technologies has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market.

Thermo Fisher Scientific has higher revenue and earnings than Agilent Technologies. Agilent Technologies is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.95B	6.33	$1.30B	$4.98	31.28
Thermo Fisher Scientific	$44.56B	5.14	$6.70B	$18.59	33.29

Summary

Agilent Technologies and Thermo Fisher Scientific tied by winning 10 of the 20 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to AMN Healthcare Services?

Thermo Fisher Scientific (NYSE:TMO) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations and earnings.

Thermo Fisher Scientific presently has a consensus price target of $619.41, indicating a potential upside of 0.09%. AMN Healthcare Services has a consensus price target of $31.43, indicating a potential downside of 10.69%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Thermo Fisher Scientific is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.78
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Thermo Fisher Scientific had 93 more articles in the media than AMN Healthcare Services. MarketBeat recorded 103 mentions for Thermo Fisher Scientific and 10 mentions for AMN Healthcare Services. Thermo Fisher Scientific's average media sentiment score of 1.60 beat AMN Healthcare Services' score of 0.82 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	98 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive
AMN Healthcare Services	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Thermo Fisher Scientific has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, indicating that its share price is 60% less volatile than the broader market.

Thermo Fisher Scientific has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	5.14	$6.70B	$18.59	33.29
AMN Healthcare Services	$2.73B	0.50	-$95.70M	$2.68	13.13

Thermo Fisher Scientific has a net margin of 15.04% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.04%	17.09%	8.12%
AMN Healthcare Services	3.06%	19.92%	5.93%

Summary

Thermo Fisher Scientific beats AMN Healthcare Services on 14 of the 17 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to Bio-Rad Laboratories?

Thermo Fisher Scientific (NYSE:TMO) and Bio-Rad Laboratories (NYSE:BIO) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

In the previous week, Thermo Fisher Scientific had 99 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 103 mentions for Thermo Fisher Scientific and 4 mentions for Bio-Rad Laboratories. Thermo Fisher Scientific's average media sentiment score of 1.60 beat Bio-Rad Laboratories' score of 1.08 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	98 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Bio-Rad Laboratories	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.2% of Thermo Fisher Scientific shares are owned by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are owned by institutional investors. 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Comparatively, 30.3% of Bio-Rad Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Thermo Fisher Scientific has higher revenue and earnings than Bio-Rad Laboratories. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	5.14	$6.70B	$18.59	33.29
Bio-Rad Laboratories	$2.58B	3.81	$759.90M	$8.25	44.58

Thermo Fisher Scientific has a net margin of 15.04% compared to Bio-Rad Laboratories' net margin of 8.59%. Thermo Fisher Scientific's return on equity of 17.09% beat Bio-Rad Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.04%	17.09%	8.12%
Bio-Rad Laboratories	8.59%	3.54%	2.48%

Thermo Fisher Scientific has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, Bio-Rad Laboratories has a beta of 1.06, suggesting that its stock price is 6% more volatile than the broader market.

Thermo Fisher Scientific currently has a consensus target price of $619.41, suggesting a potential upside of 0.09%. Bio-Rad Laboratories has a consensus target price of $343.33, suggesting a potential downside of 6.64%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, equities research analysts plainly believe Thermo Fisher Scientific is more favorable than Bio-Rad Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.78
Bio-Rad Laboratories	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Thermo Fisher Scientific beats Bio-Rad Laboratories on 14 of the 17 factors compared between the two stocks.

Get Thermo Fisher Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMO vs. The Competition

Export

Metric	Thermo Fisher Scientific	Life Sciences Tools & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$228.83B	$9.94B	$7.29B	$24.18B
Dividend Yield	0.32%	1.47%	2.55%	3.72%
P/E Ratio	33.29	59.78	269.25	30.13
Price / Sales	5.14	107.10	615.11	19.89
Price / Cash	19.38	26.08	78.23	31.97
Price / Book	4.34	38.08	13.24	6.84
Net Income	$6.70B	$56.67B	$3.47B	$1.07B
7 Day Performance	3.72%	2.42%	1.85%	-0.90%
1 Month Performance	17.65%	8.81%	4.99%	2.62%
1 Year Performance	25.07%	25.26%	28.36%	17.81%

Thermo Fisher Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMO Thermo Fisher Scientific	4.5467 of 5 stars	$618.88 +0.9%	$619.41 +0.1%	+23.4%	$228.83B	$44.56B	33.29	125,000	News Coverage Positive News
ILMN Illumina	3.2713 of 5 stars	$191.79 +2.0%	$188.40 -1.8%	+101.8%	$28.96B	$4.34B	35.78	8,650	Positive News Gap Up
MEDP Medpace	3.7515 of 5 stars	$602.43 +2.0%	$584.18 -3.0%	+31.6%	$16.81B	$2.53B	35.31	6,200	Positive News
A Agilent Technologies	4.6444 of 5 stars	$148.42 +1.7%	$159.35 +7.4%	+29.3%	$41.92B	$6.95B	29.80	18,100	Positive News Upcoming Earnings
AMN AMN Healthcare Services	2.0792 of 5 stars	$36.40 +1.1%	$30.86 -15.2%	+76.1%	$1.41B	$3.43B	13.58	2,664	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:TMO) was last updated on 8/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thermo Fisher Scientific (TMO) Competitors

TMO vs. ILMN, MEDP, A, AMN, and BIO

How does Thermo Fisher Scientific compare to Illumina?

Summary

How does Thermo Fisher Scientific compare to Medpace?

Summary

How does Thermo Fisher Scientific compare to Agilent Technologies?

Summary

How does Thermo Fisher Scientific compare to AMN Healthcare Services?

Summary

How does Thermo Fisher Scientific compare to Bio-Rad Laboratories?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMO vs. The Competition

Thermo Fisher Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Thermo Fisher Scientific (TMO) Competitors

TMO vs. ILMN, MEDP, A, AMN, and BIO

How does Thermo Fisher Scientific compare to Illumina?

Do insiders and institutionals have more ownership in TMO or ILMN?

Is TMO or ILMN more profitable?

Does the media favor TMO or ILMN?

Which has higher valuation & earnings, TMO or ILMN?

Which has more volatility & risk, TMO or ILMN?

Do analysts prefer TMO or ILMN?

Summary

How does Thermo Fisher Scientific compare to Medpace?

Which has better earnings and valuation, TMO or MEDP?

Do institutionals & insiders have more ownership in TMO or MEDP?

Is TMO or MEDP more profitable?

Does the media favor TMO or MEDP?

Do analysts recommend TMO or MEDP?

Which has more volatility and risk, TMO or MEDP?

Summary

How does Thermo Fisher Scientific compare to Agilent Technologies?

Does the media favor A or TMO?

Do analysts prefer A or TMO?

Is A or TMO more profitable?

Do institutionals & insiders believe in A or TMO?

Is A or TMO a better dividend stock?

Which has more risk and volatility, A or TMO?

Which has better earnings and valuation, A or TMO?

Summary

How does Thermo Fisher Scientific compare to AMN Healthcare Services?

Do analysts prefer TMO or AMN?

Do institutionals & insiders believe in TMO or AMN?

Does the media favor TMO or AMN?

Which has more volatility & risk, TMO or AMN?

Which has stronger earnings & valuation, TMO or AMN?

Is TMO or AMN more profitable?

Summary

How does Thermo Fisher Scientific compare to Bio-Rad Laboratories?

Does the media favor TMO or BIO?

Do insiders and institutionals have more ownership in TMO or BIO?

Which has better valuation & earnings, TMO or BIO?

Is TMO or BIO more profitable?

Which has more risk and volatility, TMO or BIO?

Do analysts prefer TMO or BIO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMO vs. The Competition

Thermo Fisher Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools